The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...

The investment includes the installation of a high-speed, state-of-the-art Groninger UFVN FlexFill syringe, cartridge, and vial filling line and a SKAN isolator to enhance production efficiency and ...

Dublin, April 30, 2026 (GLOBE NEWSWIRE)-- The "Sterile Injectables CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The sterile injectables CDMO market is witnessing ...

Dublin, May 26, 2026 (GLOBE NEWSWIRE) -- The "Sterile Injectables CDMO Market Size, Share & Trends Analysis Report by Molecule Type, Product, Service, Therapeutic Area, Route of Administration, ...

Sharp is honing its edge in the growing sterile injectables market by expanding its production capacity for secondary packaging at its facility in Macungie, Pennsylvania. Although Sharp didn’t ...

WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...

New manufacturing workers can get acquainted with the equipment and procedures at Pfizer’s upcoming sterile injectables plant without ever setting foot inside. Armed with a virtual reality wearable ...

ROIS adds a US sterile fill-finish hub, enabling lifecycle continuity from European development to US commercial supply within one CDMO network. The Phoenix facility supports vials, prefilled syringes ...

WESTON, Fla. and WHIPPANY, N.J., April 14, 2026 /PRNewswire/ - Apotex Corp. today announced that it has secured a strategic sterile filling partnership with Halo Pharmaceuticals through an investment ...

Maiva Pharma, a leading global contract manufacturing organization (CMO) and contract development and manufacturing organization (CDMO) specialising in sterile injectables, inaugurated its new ...

WILMINGTON, Del. & WHIPPANY, N.J.--(BUSINESS WIRE)--The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million ...